SpyGlass Press Release 

SpyGlass Now Available at Saint Francis Hospital – Memphis

New System Offers Improved Diagnosis and Treatment

Of Liver, Gallbladder and Bile Duct Conditions

Almost half a million people annually in the U.S. undergo a procedure called an Endoscopic Retrograde Cholangiopancreatography (ERCP) to diagnose problems in the liver, gallbladder and bile duct.  Physicians at Saint Francis Hospital – Memphis are now using a new cholangioscopy technology to diagnose and treat conditions such as obstructions and stones within the biliary tract. The device, known as the SpyGlass™ Direct Visualization System, includes a miniature 6,000-pixel fiber optic probe that provides physicians with a direct view of a patient’s bile ducts, overcoming some of the visual challenges of conventional ERCP procedures.   This leads to better diagnosis of conditions like gallstones, suspected cancers, obstructions and cystic lesions.

“We are the one and only hospital in Memphis with the SpyGlass system.  It is an exciting advancement in diagnostic care," said Mike Lachina, MD, CMO.  "SpyGlass underscores our commitment to provide high quality patient care using state-of-the-art medical technology."

            The SpyGlass System provides direct visual access into a patient’s biliary duct to improve diagnosis by helping to identify stones and obstructions. A fiber optic probe attaches to a camera head and is inserted through a single-use catheter that can be steered in four directions. This is designed to allow the user to access and inspect all four quadrants of the examination and treatment area. SpyGlass represents a significant improvement over the two-dimensional black and white images produced by the traditional ERCP procedure.